Bioretec has appointed Bachelor of Technology René Eve as the company's Director of Operations and as a member of the Management Team. Eve has over 15 years of diverse experience in production, procurement, production planning, and customer service. René Eve joins Bioretec from Next Pharma and takes up his duties on 18 August 2025. Esa Hallinen, former Director of Operations, will pursue a career outside Bioretec.

"Bioretec is significantly expanding its operations and production after obtaining both U.S. FDA approval and CE Mark approval for the RemeOs™ product family of absorbable orthopedic implants in Europe and all other countries where CE Mark is recognized. René Eve has strong expertise in the pharmaceutical industry and mass manufacturing of metal products. He will play a key role in Bioretec's growth into the next phase of commercialisation for our RemeOs and Activa™ products globally. We are excited to welcome René Eve to our experienced management team," Bioretec's interim CEO Sarah van Hellenberg Hubar-Fisher says.

"It's great to join Bioretec's innovative team and support the company's growth and international success story. I am looking forward to implementing the company's strategy and bringing the production of absorbable implants to the next level," René Eve says.